Trick or Treat? For the month of October, we are clearly handing out the goodies, with new cases Dementia and Movement Disorders, as well as several webcasts and guidelines now freely available for all with a myEAN account.
BioMed Alliance and 17 other civil society organisations call on policy makers to ensure that the next multiannual EU budget will be fit-for-purpose to address current and future health threats.
Latest Posts
-
-
With relatively few chances for EAN staff and members to meet in person, we decided to use this platform to present the team behind the scenes. This time it's Gottfried, our Head of IT, and Sylwia from the Congress Department. -
The application deadline for next year's EAN Clinical Fellowships - 31 October 2022 - is fast approaching! -
EAN NewsBreaking newsCOVID-19COVID-19 Breaking News: Cross-Sectional Case Control Studies – October 2022
Our pick of Covid-related cross-sectional case control studies from the scientific press for October 2022 -
Read on for our highlighted selection of Covid-related Literature Reviews from the scientific press for October 2022. -
Our highlighted selection of recent Covid-related case series or case reports from the scientific press for October 2022. -
Research HighlightsPerformance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome – A MAGNIMS Study
The 2017 McDonald criteria showed higher sensitivity, lower specificity, and similar accuracy in predicting clinically definite multiple sclerosis compared to 2010 McDonald criteria, while shortening time to its diagnosis. -
Research Highlights
Relapse-independent disability worsening plays a relevant role in every disease phase of MS
Insidious disability accrual starts already in the earliest phases of multiple sclerosis and becomes dominant over the disease course, suggesting an ongoing process of inflammation and/or degeneration secondary to disease burden. -
Research Highlights
Epstein-Barr virus infection is a major risk factor for the development of multiple sclerosis
Epstein-Barr virus infection is the strongest known risk factor for the development of multiple sclerosis, and it precedes preclinical manifestation of the disease suggesting a possible causal role -
In multiple sclerosis, an impairment of the glymphatic system may contribute to pathology accrual in the central nervous system and disability progression.
-
Research Highlights
Characterizing amyloid-positive individuals with persistent normal tau PET levels
Baseline characteristics of Aβ-positive individuals can help identify those who will remain tau-negative for at least 5 years. -
Greater diffusion restriction in the white matter of amyloid-beta-positive cognitively unimpaired individuals supports the role of inflammation in early preclinical AD.
-
Research Highlights
Effect of Intra-arterial Alteplase after Angiographically Successful Thrombectomy
New Neurology Update from Stroke Scientific Panel -
Other NewsWhat Makes You, You? New initiative from Alzheimer Europe looks beyond Alzheimer’s diagnosis and celebrates the person
To mark World Alzheimer Day on 21 September, Alzheimer Europe launched a new initiative called ‘What Makes You, You?’ -
The revised Boston criteria allow for a more accurate diagnosis of cerebral amyloid angiopathy